Akut mieloid leukémia (AML): vizsgálatok itt: Grúzia

3 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 1. fázisCsak meghívásos
  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Where

  Tbilisi

  Életkor

  18 év and over

  People

  120 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06788509 · EU 2024-515457-21-00
• 3. fázisTaking people
  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Where

  Batumi, Tbilisi

  Életkor

  12 év and over

  People

  468 worldwide

  Run by

  Syndax Pharmaceuticals

  See details and how to joinNCT07211958 · EU 2025-522279-27-00
• 2/3. fázisTaking people
  L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  Where

  Tbilisi

  Életkor

  18 év to 80 év

  People

  312 worldwide

  Run by

  Moleculin Biotech, Inc.

  See details and how to joinNCT06788756 · EU 2024-518359-47-00